tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

OCS Stock Latest News

Oculis Holding AG Announces 2025 AGM Results and Strategic Approvals
Company AnnouncementsOculis Holding AG Announces 2025 AGM Results and Strategic Approvals
3d ago
6K
OCS
Oculis Holding’s Promising Pipeline and Strategic Initiatives Drive Buy Rating
PremiumRatings
Oculis Holding’s Promising Pipeline and Strategic Initiatives Drive Buy Rating
27d ago
OCS
Oculis Announces 2025 Annual General Meeting Details
PremiumCompany Announcements
Oculis Announces 2025 Annual General Meeting Details
30d ago
6K
OCS
Oculis Holding AG Reports Strong Q1 Progress
PremiumCompany Announcements
Oculis Holding AG Reports Strong Q1 Progress
1M ago
OCS
Oculis Holding AG Reports Q1 2025 Financial Results
PremiumCompany Announcements
Oculis Holding AG Reports Q1 2025 Financial Results
1M ago
6K
OCS
Oculis price target raised to $32 from $29 at H.C. Wainwright
PremiumThe FlyOculis price target raised to $32 from $29 at H.C. Wainwright
2M ago
OCS
Oculis Holding’s Promising Future: Advancements in Neuroprotection, Dry Eye Treatment, and Diabetic Macular Edema
Premium
Ratings
Oculis Holding’s Promising Future: Advancements in Neuroprotection, Dry Eye Treatment, and Diabetic Macular Edema
2M ago
OCS
Oculis Holding AG Unveils Key Clinical Updates and Future Outlook at R&D Day
Premium
Company Announcements
Oculis Holding AG Unveils Key Clinical Updates and Future Outlook at R&D Day
2M ago
6K
OCS
Oculis Holding’s Promising Pipeline and Strategic FDA Alignments Support Buy Rating
PremiumRatings
Oculis Holding’s Promising Pipeline and Strategic FDA Alignments Support Buy Rating
3M ago
OCS
Oculis price target raised to $41 from $37 at Baird
PremiumThe Fly
Oculis price target raised to $41 from $37 at Baird
3M ago
OCS
Oculis price target raised to $32 from $31 at BofA
PremiumThe Fly
Oculis price target raised to $32 from $31 at BofA
3M ago
OCS
Oculis price target lowered to $29 from $30 at H.C. Wainwright
PremiumThe Fly
Oculis price target lowered to $29 from $30 at H.C. Wainwright
3M ago
OCS
Oculis Holding AG Faces Heightened Cybersecurity Risks Amid Geopolitical Tensions
PremiumCompany AnnouncementsOculis Holding AG Faces Heightened Cybersecurity Risks Amid Geopolitical Tensions
3M ago
OCS
Oculis Holding AG Reports 2024 Financial Results
Premium
Company Announcements
Oculis Holding AG Reports 2024 Financial Results
3M ago
OCS
Oculis Holding’s Promising Ophthalmology Portfolio and Financial Stability Lead to Buy Rating
Premium
Ratings
Oculis Holding’s Promising Ophthalmology Portfolio and Financial Stability Lead to Buy Rating
3M ago
OCS
Oculis Holding AG Reports 2024 Financial Results and Clinical Progress
PremiumCompany Announcements
Oculis Holding AG Reports 2024 Financial Results and Clinical Progress
3M ago
6K
OCS
Oculis 5M share Secondary priced at $20,00
PremiumThe Fly
Oculis 5M share Secondary priced at $20,00
4M ago
OCS
Oculis Holding AG Prices $100 Million Oversubscribed Share Offering
PremiumCompany Announcements
Oculis Holding AG Prices $100 Million Oversubscribed Share Offering
4M ago
6K
OCS
Oculis price target raised to $31 from $23 at BofA
PremiumThe Fly
Oculis price target raised to $31 from $23 at BofA
5M ago
OCS
Oculis Holding’s OCS-05 Shows Promising Results in Phase 2 Trial for Acute Optic Neuritis
PremiumCompany AnnouncementsOculis Holding’s OCS-05 Shows Promising Results in Phase 2 Trial for Acute Optic Neuritis
5M ago
6K
OCS
Oculis Holding (OCS): A Biopharma Opportunity for Adventurous Investors
Premium
Market News
Oculis Holding (OCS): A Biopharma Opportunity for Adventurous Investors
5M ago
OCS
Oculis Holding AG Reports Q3 2024 Financial Progress
Premium
Company Announcements
Oculis Holding AG Reports Q3 2024 Financial Progress
7M ago
OCS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >